Back to PFE Stock Lookup

PFE – Analyst Ratings

Apr 7, 2014 09:00 AM Goldman Sachs Comments on Pfizer's (PFE) Palbo
Apr 1, 2014 10:40 AM Cubist Pharma (CBST) SIVEXTRO Approval Outlook Improves; Aegis Maintains 'Buy' Rating
Mar 13, 2014 01:13 PM Early Generic Celebrex Could Be Positive for PBMs and Retailers, FBR Capital Says
Mar 12, 2014 03:56 PM Goldman Sachs Comments on Pfizer's (PFE) Celebrex Litigation and EPS Impact
Feb 28, 2014 09:02 AM Mylan (MYL) Will Have $3B in 'Firepower' by Year-End, Says Goldman Sachs
Feb 4, 2014 06:59 AM Jefferies Upgrades Pfizer (PFE) to Buy, $38 PT
Feb 3, 2014 10:19 AM Pfizer (PFE) Likely to Approach FDA about Palbociclib NDA Filing; Goldman Comments
Jan 21, 2014 01:15 PM U.S. Large Cap and Specialty Pharma Q4 Previewed at UBS (PFE) (ACT) (MYL)
Jan 10, 2014 07:43 AM Cowen Downgrades Pfizer (PFE) to Market Perform
Dec 3, 2013 08:38 AM Goldman Sachs Removes Pfizer (PFE) from CL-Buy List, AbbVie (ABBV) Added to CL-Buy List
Oct 8, 2013 04:45 PM Credit Suisse Starts Pfizer (PFE) at Outperform
Aug 30, 2013 02:29 PM Drug Companies on Watch Heading Into ESC Meeting; Goldman Comments (JNJ) (BMY) (PFE)
Jul 12, 2013 08:22 AM Jefferies Downgrades Pfizer (PFE) to Hold, Sees Downside to Consensus
Jul 10, 2013 06:49 AM Morgan Stanley Resumes Pfizer (PFE) at Overweight
Jul 2, 2013 07:45 AM Standpoint Research Downgrades Pfizer (PFE) to Sell
Jun 28, 2013 01:09 PM Goldman Sachs Comments on Biosimilar Remicade Approval in EU (HSP) (ACT) (TEVA) (NVS) (ABBV)
Jun 24, 2013 07:38 AM JPMorgan Resumes Pfizer (PFE) at Overweight
Jun 20, 2013 11:18 AM UPDATE: Craig-Hallum Starts Ligand Pharma (LGND) at Buy, Price Target $60
Jun 17, 2013 01:08 PM Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
May 29, 2013 04:44 PM SunTrust Robinson Humphrey Starts Pfizer (PFE) at Reduce
Apr 30, 2013 11:23 AM Pfizer (PFE) Q1 Results Might Signal Weakness at Merck (MRK)
Apr 25, 2013 05:58 PM EU Rejection of XELJANZ Will Cost Pfizer (PFE) Millions
Apr 10, 2013 11:17 AM Pfizer's (PFE) Palbociclib Has $5 Billion Potential
Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
Mar 19, 2013 09:46 AM Brazilian Approval a Positive for Protalix (PLX) - Oppenheimer
Mar 13, 2013 10:19 AM Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza
Feb 25, 2013 11:16 AM Jefferies Raises Estimates on Pfizer (PFE); Positive on Eliquis and Xeljanz Launches
Feb 7, 2013 06:52 AM Credit Suisse Reinstates Pfizer (PFE) at Neutral
Jan 28, 2013 09:15 AM iDividend: Apple (AAPL) Could Draw Investors Back in With 'Significantly' Larger Dividend - Barron's
Nov 30, 2012 06:50 AM Citi Starts Pfizer (PFE) at Buy
Nov 27, 2012 10:33 AM MKM Partners Downgrades Pfizer (PFE) to Neutral, Cites Weak Pipeline
Nov 21, 2012 08:37 AM Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's
Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis
Nov 12, 2012 08:11 AM Analysts Look Forward to Pfizer (PFE) Product Launches
Oct 5, 2012 11:06 AM MKM Partner Raises Price Target on Pfizer (PFE)
Sep 28, 2012 07:29 AM BMO Capital Starts Pfizer (PFE) at Outperform
Sep 10, 2012 08:43 AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty
Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM
Aug 9, 2012 01:25 PM Phizer (PFE) Will Perform Despite Difficult Second Half - Jefferies
Aug 1, 2012 01:50 PM Barclays Q2 Review on Pfizer (PFE): Will There Be Growth in 2013?
Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say
Jul 24, 2012 10:15 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: I'm Large and In Charge
Jul 18, 2012 11:13 AM Needham & Company Maintains a 'Buy' on Gilead Sciences (GILD); Q2 Preview; Quad Pill Update
Jul 16, 2012 02:27 PM Antares (ATRS) Makes New 52-Week High; Is Pfizer (PFE) Taking a Gander
Jul 13, 2012 10:33 AM Leerink Swann Maintains an 'Outperform' on Verastem (VSTM); Potential Leadership Position in FAK Inhibition
Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?
Jul 6, 2012 02:01 PM Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China
Jul 3, 2012 01:18 PM UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap
Jun 29, 2012 10:10 AM Mead Johnson (MJN) Trades Lower; Goldman Cuts Estimates, PT on New Nielsen Data
Jun 25, 2012 08:34 AM Canaccord Genuity Reiterates a 'Hold' on Protalix BioTherapeutics (PLX); Modest U.S. But Strong In Israel

Back to PFE Stock Lookup